RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.01B
AUM Growth
-$490M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
97
New
Increased
Reduced
Closed

Top Buys

1
+$19.9M
2
+$14.5M
3
+$6.54M
4
CYTK icon
Cytokinetics
CYTK
+$5.34M
5
ABMD
Abiomed Inc
ABMD
+$5.3M

Top Sells

1
+$31.6M
2
+$25.4M
3
+$25.1M
4
JNJ icon
Johnson & Johnson
JNJ
+$24.8M
5
PFE icon
Pfizer
PFE
+$24.7M

Sector Composition

1 Healthcare 98.1%
2 Industrials 1.09%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$3.2M 0.32%
235,210
+49,000
77
$3.16M 0.31%
15,000
-100,000
78
$3.08M 0.3%
117,000
-6,465
79
$2.97M 0.29%
797,330
-2,670
80
$2.88M 0.28%
735,000
-40,000
81
$2.63M 0.26%
71,000
-4,000
82
$2.54M 0.25%
410,923
-9,077
83
$2.53M 0.25%
287,081
-13,572
84
$2.47M 0.24%
140,000
85
$2.4M 0.24%
316,137
-8,863
86
$2.13M 0.21%
500,000
87
$2.04M 0.2%
300,000
+103,913
88
$909K 0.09%
3,750
89
$683K 0.07%
250,000
90
– –
-8,000
91
– –
-59,000
92
– –
-150,000
93
– –
-115,000
94
– –
-92,700
95
– –
-60,000
96
– –
-265,000
97
– –
-60,000
1 2 3
4